Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Monoclonal antibody passive experimental autoimmune myasthenia gravis: current progress and future directions. | Cell Biosci | 2026 | 42216051 | PubTator, text mining | PubMed |
| Comprehensive review on myasthenia gravis: patho-physiology, diagnosis, management strategies. | Wien Med Wochenschr | 2026 | 42166045 | PubTator, text mining | PubMed |
| Exploring the role of circulating glial fibrillary acidic protein and neurofilament light chain in myasthenia gravis. | Clin Chim Acta | 2026 | 42081930 | PubTator, text mining | PubMed |
| A Case of Myasthenia Gravis Diagnosed After Hospitalization in a Patient Receiving Home Oxygen Therapy for Respiratory Failure. | Acute Med Surg | 2026 | 42046766 | PubTator, text mining | PubMed |
| Successful treatment with eculizumab in refractory myasthenia gravis with both anti-AChR and anti-LRP4 antibodies: two case reports. | J Neuroimmunol | 2026 | 42035597 | PubTator, text mining | PubMed |
| Failure of early B cell tolerance and possible BCR signaling dysregulation underlie NF155-mediated autoimmune nodopathies. | Proc Natl Acad Sci U S A | 2026 | 42008666 | PubTator, text mining | PubMed |
| Enhanced antibody detection via live cell-based assay among RIA negative myasthenia gravis patients: toward improved diagnosis and clinical correlates. | J Neurol | 2026 | 41998298 | PubTator, text mining | PubMed |
| Clinical Characteristics of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort. | Pediatr Neurol | 2026 | 41974154 | PubTator, text mining | PubMed |
| Molecular structure of the third immunoglobulin domain (Ig3) of human Muscle-Specific kinase (MuSK). | J Struct Biol | 2026 | 41956176 | PubTator, text mining | PubMed |
| Hidden diagnoses among patients with double seronegative myasthenia gravis. | Front Neurol | 2026 | 41940306 | PubTator, text mining | PubMed |
| A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation. | Int J Circumpolar Health | 2026 | 41919672 | PubTator, text mining | PubMed |
| Ophthalmoplegia Caused by Non-Aneurysm Neurovascular Conflict: Clinical Cases of Eight Patients. | Rev Neurol | 2026 | 41914338 | PubTator, text mining | PubMed |
| Selective Depletion of Autoreactive Plasma Cells as a Novel Strategy to Treat Acetylcholine Receptor Antibody-Positive Myasthenia Gravis. | Eur J Immunol | 2026 | 41906599 | PubTator, text mining | PubMed |
| Myasthenia Gravis in Pregnancy: Prenatal and Postnatal Diagnostic Challenges-A Narrative Review. | Diagnostics (Basel) | 2026 | 41897632 | PubTator, text mining | PubMed |
| Development of Stereotypic Behaviors and Personality Traits of Captive Male Forest Musk Deer and Relationships with Musk Secretion. | Vet Sci | 2026 | 41893678 | PubTator, text mining | PubMed |
| Epigenetics of Genes Displaying High and Preferential Expression in Myoblasts. | Epigenomes | 2026 | 41892369 | PubTator, text mining | PubMed |
| Burden of glucocorticoid use in commercially insured adults with generalized myasthenia gravis in the United States: A retrospective claims-based analysis. | Medicine (Baltimore) | 2026 | 41861184 | PubTator, text mining | PubMed |
| Application of Droplet Digital PCR in Sputum Samples in Myasthenia Gravis Patients with Pneumonia. | Infect Drug Resist | 2026 | 41809936 | PubTator, text mining | PubMed |
| Efficacy and safety of anti-CD20 monoclonal antibody therapy for autoimmune nodopathies: a systematic review and meta-analysis. | Front Neurol | 2026 | 41809187 | PubTator, text mining | PubMed |
| Late-Onset Ocular Myasthenia Gravis-Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report. | Biologics | 2026 | 41808843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=3